KIF2A silencing inhibits the proliferation and migration of breast cancer cells and correlates with unfavorable prognosis in breast cancer

BMC Cancer

Volumn 14, Issue 1, 2014, Pages

  Wang, Jianli ^a   Ma, Siqin ^a   Ma, Rong ^b   Qu, Xun ^b   Liu, Wenjun ^a   Lv, Cuixia ^c   Zhao, Song ^b   Gong, Yunyun ^d  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

^c Shandong Center for Disease Control and Prevention   (China)

^d QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Breast cancer; Invasion; KIF2A; Marker; Migration; Survival

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; KINESIN FAMILY MEMBER 2A; MOLECULAR MOTOR; PROGESTERONE RECEPTOR; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; KIF2A PROTEIN, HUMAN; KINESIN;

ADULT; AGE; AGED; ARTICLE; BREAST CANCER; BREAST CANCER CELL LINE; BREAST CARCINOGENESIS; CANCER CELL; CANCER GRADING; CANCER GROWTH; CANCER PROGNOSIS; CANCER SIZE; CANCER SPECIFIC SURVIVAL; CANCER TISSUE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENE EXPRESSION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MDA MB 231 CELL LINE; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; SURVIVAL TIME; WESTERN BLOTTING; BREAST TUMOR; CANCER STAGING; CELL MOTION; GENETICS; METABOLISM; METASTASIS; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; RNA INTERFERENCE; TUMOR CELL LINE; TUMOR VOLUME; YOUNG ADULT;

ADULT; AGED; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; FEMALE; GENE EXPRESSION; GENE SILENCING; HUMANS; IMMUNOHISTOCHEMISTRY; KINESIN; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM METASTASIS; NEOPLASM STAGING; PROGNOSIS; RNA INTERFERENCE; TUMOR BURDEN; YOUNG ADULT;

EID: 84902753378     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-14-461     Document Type: Article

References (29)

1. Breast cancer in developing countries. Lancet 2009, 374:1567.
2. Ginsburg OM, Love RR. Breast cancer: a neglected disease for the majority of affected women worldwide. Breast J 2011, 17:289-95.
3. Malvezzi M, Bertuccio P, Levi F, La Vecchia C, Negri E. European cancer mortality predictions for the year 2013. Ann Oncol 2013, 24:792-800.
4. Moore A, Wordeman L. The mechanism, function and regulation of depolymerizing kinesins during mitosis. Trends Cell Biol 2004, 14:537-546.
5. Manning AL, Ganem NJ, Bakhoum SF, Wagenbach M, Wordeman L, Compton DA. The kinesin-13 proteins KIF2A, KIF2B, and KIF2C/MCAK have distinct roles during mitosis in human cells. Mol Biol Cell 2007, 18:2970-2979.
6. Wittmann T, Hyman A, Desai A. The spindle: a dynamic assembly of microtubules and motors. Nat Cell Biol 2001, 3:E28-34.
7. Shimo A, Tanikawa C, Nishidate T, Lin ML, Matsuda K, Park JH, Ueki T, Hirata K, Fukuda M, Nakamura Y, Katagiri T. Involvement of kinesin family member 2C/mitotic centromere-associated kinesin overexpression in mammary carcinogenesis. Cancer Sci 2008, 99:62-70.
8. Tomonaga T, Matsushita K, Ishibashi M, Nezu M, Shimada H, Ochiai T, Yoda K, Nomura F. Centromere protein H is up-regulated in primary human colorectal cancer and its overexpression induces aneuploidy. Cancer Res 2005, 65:4683-4689.
9. Ishikawa K, Kamohara Y, Tanaka F, Haraguchi N, Mimori K, Inoue H, Mori M. Mitotic centromere-associated kinesin is a novel marker for prognosis and lymph node metastasis in colorectal cancer. Br J Cancer 2008, 98:1824-1829.
10. Vale RD, Fletterick RJ. The design plan of kinesin motors. Annu Rev Cell Dev Biol 1997, 13:745-777.
11. Hirokawa N, Noda Y, Okada Y. Kinesin and dynein superfamily proteins in organelle transportand cell division. Curr Opin Cell Biol 1998, 10:60-73.
12. Sharp DJ, Rogers GC, Scholey JM. Microtubule motors in mitosis. Nature 2000, 407:41-47.
13. Kline-Smith SL, Walczak CE. Mitotic spindle assembly and chromosome segregation: refocusing on microtubule dynamics. Mol Cell 2004, 15:317-327.
14. Homma N, Takei Y, Tanaka Y, Nakata T, Terada S, Kikkawa M, Noda Y, Hirokawa N. Kinesin superfamily protein 2A (KIF2A) functions in suppression of collateral branch extension. Cell 2003, 114:229-239.
15. Noda Y, Niwa S, Homma N, Fukuda H, Imajo-Ohmi S, Hirokawa N. Phosphatidylinositol 4-phosphate 5-kinase alpha (PIPKα) regulates neuronal microtubule depolymerase kinesin, KIF2A and suppresses elongation of axon branches. Proc Natl Acad Sci U S A 2012, 109:1725-30.
16. Ganem NJ, Compton DA. The KinI kinesin KIF2A is required for bipolar spindle assembly through a functional relationship with MCAK. J Cell Biol 2004, 166:473-478.
17. Wang JL, Sun SZ, Qu X, Liu WJ, Wang YY, Lv CX, Sun JZ, Ma R. Clinicopathological Significance of CEACAM1 Gene Expression in Breast Cancer. Chin J Physiol 2011, 54:332-338.
18. Harvey JM, Clark GM, Osborne CK, Allred DC. Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol 1999, 17:1474-1481.
19. Pinhel I, Hills M, Drury S, Salter J, Sumo G, A'Hern R, Bliss JM, Sestak I, Cuzick J, Barrett-Lee P, Harris A, Dowsett M, . NCRI Adjuvant Breast Cancer Trial Management Group ER and HER2 expression are positively correlated in HER2 non-overexpressing breast cancer. Breast Cancer Res 2012, 14:R46. NCRI Adjuvant Breast Cancer Trial Management Group.
20. Honore S, Pasquier E, Braguer D. Understanding microtubule dynamics for improved cancer therapy. Cell Mol Life Sci 2005, 62:3039-56.
21. Lawrence CJ, Dawe RK, Christie KR, Cleveland DW, Dawson SC, Endow SA, Goldstein LS, Goodson HV, Hirokawa N, Howard J, Malmberg RL, McIntosh JR, Miki H, Mitchison TJ, Okada Y, Reddy AS, Saxton WM, Schliwa M, Scholey JM, Vale RD, Walczak CE, Wordeman L. A standardized kinesin nomenclature. J Cell Biol 2004, 167:19-22.
22. Miki H, Okada Y, Hirokawa N. Analysis of the kinesin superfamily: insights into structure and function. Trends Cell Biol 2005, 15:467-76.
23. Helenius J, Brouhard G, Kalaidzidis Y, Diez S, Howard J. The depolymerizing kinesin MCAK uses lattice diffusion to rapidly target microtubule ends. Nature 2006, 441:115-119.
24. Kline-Smith SL, Walczak CE. The microtubule-destabilizing kinesin XKCM1 regulates microtubule dynamic instability in cells. Mol Biol Cell 2002, 13:2718-2731.
25. Holmfeldt P, Stenmark S, Gullberg M. Differential functional interplay of TOGp/XMAP215 and the KinI kinesin MCAK during interphase and mitosis. EMBO J 2004, 23:627-637.
26. Nakamura Y, Tanaka F, Haraguchi N, Mimori K, Matsumoto T, Inoue H, Yanaga K, Mori M. Clinicopathological and biological significance of mitotic centromere-associated kinesin overexpression in human gastric cancer. Br J Cancer 2007, 97:543-549.
27. Gaetz J, Kapoor TM. Dynein/dynactin regulate metaphase spindle length by targeting depolymerizing activities to spindle poles. J Cell Biol 2004, 166:465-471.
28. Zhu C, Zhao J, Bibikova M, Leverson JD, Bossy-Wetzel E, Fan JB, Abraham RT, Jiang W. Functional analysis of human microtubule-based motor proteins, the kinesins and dyneins, in mitosis/cytokinesis using RNA interference. Mol Biol Cell 2005, 16:3187-3199.
29. Wang CQ, Qu X, Zhang XY, Zhou CJ, Liu GX, Dong ZQ, Wei FC, Sun SZ. Overexpression of KIF2A promotes the progression and metastasis of squamous cell carcinoma of the oral tongue. Oral Oncol 2010, 46:65-69.